![]() |
![]() Representing the rights of employees with knowledge of fraudulent conduct. |
| Home | Steps to Whistleblowing | About Us | FAQ | Resources | False Claims Act | Retaining Our Firm | Respected Law Firm | Contact Us |
| OIG Compliance Program Guidance for Pharmaceutical Manufacturers SUPPLEMENTARY INFORMATION: Background Compliance program guidance is a major initiative of the OIG in its effort to engage the health care community in preventing and reducing fraud and abuse in federal health care programs. The purpose of the compliance program guidance is to encourage the use of internal controls to efficiently monitor adherence to applicable statutes, regulations and program requirements. In the last several years, the OIG has developed and issued compliance program guidance directed at the following segments of the health care industry: the hospital industry; home health agencies; clinical laboratories; third-party medical billing companies; the durable medical equipment, prosthetics, orthotics and supply industry; Medicare+Choice organizations offering coordinated care plans; hospices; nursing facilities; individual and small group physician practices; and ambulance suppliers. Copies of these compliance program guidances can be found on the OIG Web site at http://oig.hhs.gov/fraud/complianceguidance.html. ← Main | Developing the Compliance Program Guidance →Toll Free: 800-FRAUD 04 Nolan Law Firm - 435 North Andrews Avenue, Suite 401, Ft Lauderdale, FL 33301 Home | About Nolan Law Firm | Frequently Asked Questions | Whistleblower Resources Overviews: The hiring of a lawyer is an important decision that should not be based solely on advertisements. Before you decide, ask us to send you free written information about our qualifications and experience. Disclaimer | Copyright © 2006 Nolan Law Firm All Rights Reserved. |